SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ -- MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches ...
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
On Tuesday the American Cancer Society (ACS) released its annual report on cancer statistics in the U.S., and it offered a ...
A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...
Exact Science’s Michelle Beidelschies, PhD, reveals how a multi-biomarker class multi-cancer early detection test (MCED) blood test can help health systems expand detection across more cancers earlier ...
The world’s first early-detection blood test for pancreatic cancer is set to be launched in Australia, and is predicted to ...
New study shows that in women with BRCA1 or BRCA2 mutations, their breast cells already carry a clear pattern of DNA “damage ...
Combining virtual dental care with licensed dentists and an innovative oral cancer diagnostics solution ensures all ...
SurvivorNet on MSN
Cancer patients are living longer — a closer look at the treatments driving this progress
New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback